Abstract
Objective. To evaluate the diagnostic performance of 18F-2-deoxy-2-fluoro-d-glucose-positron emission tomography (FDG-PET) in the evaluation of breast cancer recurrence and metastases.
Data Sources. Articles published in medical journals during January 1995–June 2004 were identified by a systematic Medline search, supplemented by a manual search of the references listed in original and review articles.
Study Selection. Studies that evaluated FDG-PET with a dedicated camera for the diagnosis of breast cancer recurrence or metastases, and reporting sufficient data to permit calculation of sensitivity and specificity, were included in the analysis.
Data Extraction. Two reviewers independently reviewed the eligibility and abstracted data regarding the sample population, technical imaging characteristics of FDG-PET, and the number of true positives, true negatives, false positives and false negatives. Differences between readers were resolved by consensus.
Data Synthesis. We used meta-analytic methods to estimate the pooled sensitivity, false positive rate, and the maximum joint sensitivity and specificity. Eighteen studies met the inclusion criteria. Sixteen studies included patient-based data, comprising a sample size of 808 subjects, and eight studies included lesion-based data, totaling 1013 lesions. Among the studies with patient-based data, the median sensitivity was 92.7%, and the median specificity was 81.6%. The pooled sensitivity was 90% [95% confidence interval (86.8–93.2)], and the pooled false positive rate was 11% [95% confidence interval (7.8–14.6)], after the exclusion of outliers. The maximum joint sensitivity and specificity, was 88% [95% confidence interval (86.0–90.6)].
Conclusion. These results indicate that FDG-PET is a valuable tool for detecting breast cancer recurrence and metastases.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.References
American Cancer Society: Breast Cancer Facts and Figures. American Cancer Society, Atlanta, GA, 2002, pp. 9–10.
Ries LAG, Eisner MP, Kosary CL, et al. (eds): SEER Cancer Statistics Review, 1975–2001 National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2001, 2004
O Warburg (Eds) (1930) The metabolism of tumors Arnold Constable London 75–327
G Di Chiro RL DeLaPaz RA Brooks et al. (1982) ArticleTitleGlucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography Neurology 32 1323–1329 Occurrence Handle6983044 Occurrence Handle1:STN:280:BiyD28zivVA%3D
R Hustinx F Benard A Alavi (2002) ArticleTitleWhole-body FDG-PET imaging in the management of patients with cancer Semin Nucl Med 32 35–46 Occurrence Handle11839068
SS Gambhir J Czermin J Schwimmer et al. (2001) ArticleTitleA tabulated summary of the FDG PET literature. J Nucl Med 42 1S–93S Occurrence Handle1:STN:280:DC%2BD3Mvjs1Wgtw%3D%3D Occurrence Handle11483694
J Czermin M Phelps (2002) ArticleTitlePositron emission tomography scanning: current and future applications Annu Rev Med 53 89–112
H Bender J Kirst H Palmedo et al. (1997) ArticleTitleValue of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma Anticancer Research 17 1687–1692 Occurrence Handle9179219 Occurrence Handle1:STN:280:ByiA383nt10%3D
WB Eubank DA Mankoff J Tagasugi et al. (2001) ArticleTitle 18Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer J Clin Oncol 19 3516–3523 Occurrence Handle11481358 Occurrence Handle1:STN:280:DC%2BD3MvjtlOmtQ%3D%3D
IC Smith KN Ogston P Whitford et al. (1998) ArticleTitleStaging the axilla in breast cancer. accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-d-glucose. Annals of Surgery 228 220–227 Occurrence Handle9712568 Occurrence Handle1:STN:280:DyaK1czns1CisQ%3D%3D
M Ohta Y Tokuda Y Suzuki et al. (2001) ArticleTitleWhole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy Nuclear Medicine Communications 22 875–879 Occurrence Handle11473206 Occurrence Handle1:CAS:528:DC%2BD3MXmsVymsb0%3D
J Dose C Bleckman S Bachman et al. (2002) ArticleTitleComparison of flurodeoxyglucose positron emission tomography and conventional diagnostic procedures for the detection of distant metastases in breast cancer patients Nuclear Medicine Communications 23 857–864 Occurrence Handle12195090 Occurrence Handle1:CAS:528:DC%2BD38Xntlyhsb0%3D
XH Zhou DK McClish NA Obuchowski (2002) Statistical Methods in Diagnostic Medicine Wiley Interscience New York 222–240
L Irwig A Tosteson C Gatsonis et al. (1994) ArticleTitleGuidelines for meta-analyses evaluating diagnostic tests Ann Int Med 120 667–676 Occurrence Handle8135452 Occurrence Handle1:STN:280:ByuC1c3otlA%3D
MK Gould WG Kuschner CE Rydzak et al. (2003) ArticleTitleTest performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small cell lung cancer. A meta-analysis. Ann Intern Med 29 879–892
HR Schelbert CK Hoh HD Royal et al. (1998) ArticleTitleProcedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine. J Nucl Med 39 1302–1305 Occurrence Handle9669415 Occurrence Handle1:STN:280:DyaK1czjt1Skug%3D%3D
LE Moses D Shapiro B Littenberg (1993) ArticleTitleCombining independent studies of a diagnostic test into a summary ROC curve: data analytic approaches and some additional considerations. Stat Med 12 1293–1316 Occurrence Handle8210827 Occurrence Handle1:STN:280:ByuD38zlslw%3D
StataCorp Stata statistical software: release 7.0. Stata Corporation, College Station, TX 2001.
W Siggelkow M Zimmy A Faridi et al. (2003) ArticleTitleThe value of positron emission tomography in the follow-up for breast cancer Anticancer Res 23 1859–1868 Occurrence Handle12820470
WB Eubank DA Mankoff J Takasugi et al. (2001) ArticleTitle 18Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer J Clin Oncol 19 3516–3523 Occurrence Handle11481358 Occurrence Handle1:STN:280:DC%2BD3MvjtlOmtQ%3D%3D
GJ Cook S Houston R Rubens (1998) ArticleTitleDetection of bone metastases in breast cancer by 18FDG-PET: different metabolic activity in osteoblastic and osteolytic lesions J Clin Oncol 16 3375–3379 Occurrence Handle1:STN:280:DyaK1cvltV2qtw%3D%3D Occurrence Handle9779715
H Schirrmeister A Guhlman J Kotzerke et al. (1999) ArticleTitleEarly detection and accurate description of extent of metastatic bone disease in breast cancer with fluorine ion and positron emission tomography J Clin Oncol 17 2381–2389 Occurrence Handle1:STN:280:DC%2BD3c%2FjtVShuw%3D%3D Occurrence Handle10561300
M Petrén-Mallmin I Andréasson O Ljunggren et al. (1998) ArticleTitleSkeletal metastases from breast cancer: Uptake of 18F-fluoride measured with positron emission tomography in correlation with CT Skeletal Radiol 27 72–76 Occurrence Handle10.1007/s002560050340 Occurrence Handle1:STN:280:DyaK1c7oslGiuw%3D%3D Occurrence Handle9526771
AP Pecking C Mechelany-Corone F Bertrand-Kermorgant et al. (2001) ArticleTitleDetection of occult disease in breast cancer using fluorodeoxyglucose camera-based positron emission tomography Clin Breast Cancer 2 229–234 Occurrence Handle10.3816/CBC.2001.n.026 Occurrence Handle11899417 Occurrence Handle1:STN:280:DC%2BD387mvVagtg%3D%3D
D Grahek F Montravers K Kerrou et al. (2004) ArticleTitle[18F] FDG in recurrent breast cancer: diagnostic performance, clinical impact and relevance of induced changes in management Eur J Nucl Med Mol Imaging 31 179–188 Occurrence Handle15129699
J Hoeven Particlevan der NC Krak OS Hoekstra et al. (2004) ArticleTitle 18F-2-Fluoro-2-deoxy-D-glucose positron emission tomography in staging of locally advanced breast cancer J Clin Oncol 31 179–188
CS Liu YY Shen CC Lin et al. (2002) ArticleTitleClinical impact of [(18)F]FDG-PET in patients with suspected recurrent breast cancer based on asymptomatically elevated tumor marker serum levels: a preliminary report Jpn J Clin Oncol 32 244–247 Occurrence Handle12324574
M Lonneux I Borbath M Berliere et al. (2000) ArticleTitleThe place of whole body PET FDG for the diagnosis of distant recurrence of breast cancer Clin Positron Imaging 3 45–49 Occurrence Handle10838399
KG Gallowitsch I Igerc P Mikosch et al. (2003) ArticleTitleF-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging Invest Radiol 38 250–256 Occurrence Handle10.1097/00004424-200305000-00002 Occurrence Handle12750613
GW Goerres SC Michel MK Fehr et al. (2003) ArticleTitleFollow-up of women with breast cancer: comparison between MRI and FDG PET Eur Radiol 13 1635–1644 Occurrence Handle10.1007/s00330-002-1720-8 Occurrence Handle12835979
KF Hubner GT Smith JA Thie et al. (2000) ArticleTitleThe potential of F-18-FDG PET in breast cancer: detection of primary lesions, axillary lymph node metastases or distant metastases Clin Positron Imaging 3 197–205 Occurrence Handle11348848
D Samson CR Flamm ED Pisano et al. (2002) ArticleTitleShould FDG PET be used to decide whether a patient with an abnormal mammogram or breast finding at physical examination should undergo biopsy Acad Radiol 9 773–783 Occurrence Handle12139091
L Irwig P Macaskill P Glasziou et al. (1995) ArticleTitleMeta-analytic methods for diagnostic test accuracy J Clin Epidemiol 48 119–130 Occurrence Handle7853038 Occurrence Handle1:STN:280:ByqC2MnhtFU%3D
J Lijmer PM Bossuyt SH Heisterkamp (2002) ArticleTitleExploring sources of heterogeneity in systematic reviews of diagnostic tests Statist Med 21 1525–1537
SG Thompson (1994) ArticleTitleSystematic review: why sources of heterogeneity in meta-analysis should be investigated BMJ 309 1351–1355 Occurrence Handle7866085 Occurrence Handle1:STN:280:ByqC2s%2Fjs1c%3D
MK Gould CC Maclean WG Kuschner et al. (2001) ArticleTitleAccuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis JAMA 285 914–924 Occurrence Handle10.1001/jama.285.7.914 Occurrence Handle1:STN:280:DC%2BD3M7ltF2isA%3D%3D Occurrence Handle11180735
BA Dwamena SS Sonnad JO Angobaldo et al. (1999) ArticleTitleMetastases from non-small cell lung cancer: mediastinal staging in the 1990s–meta-analytic comparison of PET and CT Radiology 213 530–536 Occurrence Handle1:STN:280:DC%2BD3c%2FhvV2gtg%3D%3D Occurrence Handle10551237
RH Huebner KC Park JE Sheperd et al. (2000) ArticleTitleA meta-analysis of the literature for whole body FDG PET detection of recurrent colorectal cancer J Nucl Med 41 1177–1189 Occurrence Handle10914907 Occurrence Handle1:STN:280:DC%2BD3czpslemtw%3D%3D
K Kinkel Y Lu M Both et al. (2002) ArticleTitleDetection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR Imaging, PET): a meta-analysis Radiology 224 748–756 Occurrence Handle12202709
H Moon J Maddahi D Silverman JA Glaspy et al. (1998) ArticleTitleAccuracy of whole body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma J Nucl Med 39 431–435 Occurrence Handle9529287 Occurrence Handle1:STN:280:DyaK1c7ovVWgtA%3D%3D
PB Hathaway DA Mankoff KR Maravilla et al. (1999) ArticleTitleValue of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience Radiology 210 807–814 Occurrence Handle1:STN:280:DyaK1M3itlyqsA%3D%3D Occurrence Handle10207485
AY Rostom J Powe A Kandil et al. (1999) ArticleTitlePositron emissi1999; on tomography in breast cancer: a clinicopathological correlation of results Br J Radiol 72 1064–1068 Occurrence Handle10700822 Occurrence Handle1:STN:280:DC%2BD3c7msFKnuw%3D%3D
TS Kim WK Moon DS Lee et al. (2001) ArticleTitleFluorodeoxyglucose positron emission tomography for detection of recurrent metastatic breast cancer World Surg 257 829–834
M Suarez MJ Perez-Castejon A Jimenez et al. (2002) ArticleTitleEarly diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers Q J Nucl Med 46 113–121 Occurrence Handle12114874 Occurrence Handle1:STN:280:DC%2BD38zntVCisQ%3D%3D
EM Kamel MT Wyss MK Fehr et al. (2003) ArticleTitle[18F]-fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer J Clin Oncol 129 147–153
WY Lin Sc Tsai KY Cheng et al. (2002) ArticleTitleFluorine-18 FDG-PET in detecting local recurrence and distant metastases in breast cancer–Taiwanese experiences Cancer Invest 20 725–729 Occurrence Handle12197228
SN Yang JA Liang FJ Lin et al. (2002) ArticleTitleComparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer J Cancer Res Clin Oncol 128 325–328 Occurrence Handle12073051 Occurrence Handle1:STN:280:DC%2BD38zivFOhsw%3D%3D
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Isasi, C.R., Moadel, R.M. & Blaufox, M.D. A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res Treat 90, 105–112 (2005). https://doi.org/10.1007/s10549-004-3291-7
Issue Date:
DOI: https://doi.org/10.1007/s10549-004-3291-7